Today: 21 May 2026
Browse Category

NASDAQ:CRWD 28 September 2025 - 30 November 2025

10 Best Stocks to Buy Now for the Week of December 1–5, 2025: AI, Cybersecurity and Retail in Focus

10 Best Stocks to Buy Now for the Week of December 1–5, 2025: AI, Cybersecurity and Retail in Focus

U.S. stocks hovered near record highs as traders bet on an 80–85% chance the Federal Reserve will cut rates at its December 9–10 meeting, CME FedWatch data showed. The S&P 500 is up about 16% this year, but volatility in major AI stocks like Nvidia and Alphabet has raised concerns over the pace of AI-driven profits. Investors await key earnings and economic data during the week of December 1–5.
CrowdStrike (CRWD) Stock on November 29, 2025: Analyst Upgrades, Big Money Flows and AI Deals Ahead of Q3 Earnings

CrowdStrike (CRWD) Stock on November 29, 2025: Analyst Upgrades, Big Money Flows and AI Deals Ahead of Q3 Earnings

CrowdStrike shares traded near $509 on November 29, 2025, valuing the company at about $128 billion. DA Davidson raised its price target to $580 ahead of the Q3 earnings report due December 2. The stock remains up over 40% year-to-date despite an 8% pullback in the past month. Analysts remain largely positive, citing strong AI-driven demand and product momentum.
CrowdStrike (CRWD) Stock Rises to $509 as Flex, AI and SIEM Momentum Build Ahead of Q3 Earnings – November 28, 2025

CrowdStrike (CRWD) Stock Rises to $509 as Flex, AI and SIEM Momentum Build Ahead of Q3 Earnings – November 28, 2025

CrowdStrike shares closed at $509.16 on November 28, up 1.5% in light post-holiday trading, outperforming major indexes. The stock remains about 10% below its November high despite a year-to-date gain of over 50%. Evercore ISI reiterated its “In Line” rating with a $430 target, citing improving Falcon Flex momentum. Recent analyst targets have climbed as CrowdStrike’s AI and SIEM offerings draw attention ahead of earnings.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 28.11.2025

NVIDIA shares fell 14.5% in November, despite a 28% year-to-date gain. A discounted cash flow model values the stock at $165.42 per share, about 7% below its current price. CrowdStrike surged 47.2% over the past year but trades 12.6% above its DCF-based fair value. SMX stock doubled intraday on November 29, with volume nearly nine times average, as speculative trading spiked.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 19.11.2025

Ulta Beauty fell 1.9% to $497.72, underperforming the S&P 500's 0.38% gain, as investors await Q2 earnings. Nutanix dipped 0.18% to $72.07 but remains up 10.3% over the month. CrowdStrike rose 1.85% ahead of earnings, with a Forward P/E of 75.02. Okta dropped 1.14% to $80.11, down 9.41% for the month.
CrowdStrike Stock: Rosenblatt Hikes Price Target to $630 as AI Security Alliances and Google Recognition Ignite Wall Street

CrowdStrike Stock: Rosenblatt Hikes Price Target to $630 as AI Security Alliances and Google Recognition Ignite Wall Street

Rosenblatt raised its price target for CrowdStrike to $630 on November 18, 2025, citing strong AI security partnerships, including new alliances with Google Cloud. Capital One and Berenberg also lifted their targets to $599 and $600, respectively. Recent analyst upgrades have pushed CrowdStrike’s one-year target range to $540–$630.
CrowdStrike (CRWD) Stock Soars on AI Cybersecurity Boom — Record Highs

CRWD Stock Today (Nov 15, 2025): CrowdStrike’s AI Push, New Partnerships and What to Expect Into December Earnings

CrowdStrike shares remain near record highs after announcing new AI security products, partnerships with F5, Google, and CoreWeave, and a major EY contract in November. The stock hit an all-time closing high of $557.53 on Nov. 10, 2025, and now trades in the $530s. Analysts remain positive ahead of CrowdStrike’s earnings call set for Dec. 2.
CrowdStrike (CRWD) news today — Nov 12, 2025: F5 alliance embeds Falcon in BIG‑IP, RBC lifts price target to $621, and CEO Kurtz linked to Mercedes F1 stake

CrowdStrike (CRWD) news today — Nov 12, 2025: F5 alliance embeds Falcon in BIG‑IP, RBC lifts price target to $621, and CEO Kurtz linked to Mercedes F1 stake

CrowdStrike and F5 announced integration of Falcon security into BIG-IP appliances, free for eligible customers through October 2026. RBC raised CrowdStrike’s price target to $621. Reuters reports CEO George Kurtz is in talks to buy about 5% of Mercedes F1. CRWD shares traded down 0.7% at $552.71 mid-session.
12 November 2025
5 AI Stocks Set to Soar: Best Buys for October 2025’s Tech Boom

AI Stocks Fall on November 6, 2025: Nvidia, AMD, Palantir Lead Slide as Valuation Jitters Return

U.S. stocks with heavy AI exposure fell sharply Thursday, with AMD down 8%, Salesforce off 6.6%, and Nvidia losing 2.6% by late morning. Microsoft, Amazon, and other megacaps also slipped as renewed tech selling and macro uncertainty weighed on markets. Datadog jumped 22% after strong results, bucking the broader decline. Tariff questions and mixed economic data added to pressure on high-growth tech shares.
CrowdStrike (CRWD) Stock Soars on AI Cybersecurity Boom — Record Highs

CrowdStrike (CRWD) Stock Soars on AI Cybersecurity Boom — Record Highs

CrowdStrike closed at $521.98 on Oct. 23, just below its all-time high, after rising nearly 40% year-to-date. Q2 FY2026 revenue reached $1.17 billion, up 21% year-over-year, with EPS of $0.93, both beating estimates. The company acquired Onum for $290 million and launched new AI security features. About 28 of 48 analysts rate CRWD a Buy, with average price targets near $496.
AI Stock Frenzy: Growth Stocks Go Parabolic as Tech Rally Surges

AI Stock Frenzy: Growth Stocks Go Parabolic as Tech Rally Surges

The Nasdaq hit about 22,680 and the S&P 500 hovered near 6,664 as investors poured into AI-driven growth stocks. Nvidia surged nearly 60% year-over-year, while AMD almost doubled in 2025 after major AI chip deals. CrowdStrike traded near record highs, up 56% annually. Analysts remain bullish, but some warn valuations are stretched.
CrowdStrike Stock Skyrockets Amid Cybersecurity Boom – Is the Rally Justified? (2025 Update)

CrowdStrike Stock Climbs on AI Cybersecurity Momentum and Analyst Upgrades – What’s Next for CRWD?

CrowdStrike shares closed at $484.65 Friday, up 0.5% for the day but slightly down for the week, near record highs. The company was named a “Visionary” in Gartner’s 2025 Magic Quadrant for SIEM and expanded its AI security partnership with Wipro. Last quarter, revenue rose 21% to $1.17 billion with EPS of $0.93, beating estimates. Wall Street remains bullish, with most analysts rating the stock a Buy.
19 October 2025
CrowdStrike Stock Skyrockets Amid Cybersecurity Boom – Is the Rally Justified? (2025 Update)

CrowdStrike Stock Skyrockets Amid Cybersecurity Boom – Is the Rally Justified? (2025 Update)

CrowdStrike shares trade near $500 after a 65% year-on-year surge, giving the cybersecurity firm a $125 billion market cap and a valuation of about 135 times forward earnings. The company agreed in August to buy Onum for $290 million and unveiled new AI-powered security features in September. Revenue rose 21% last quarter to $740 million with EPS of $0.93. Wall Street remains broadly bullish, with most analysts rating the stock a Buy.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Nasdaq Surges Amid AI Frenzy and Fed Optimism – EA Skyrockets on $50B Buyout Buzz

The Nasdaq Composite closed at 22,484.07 on Sept. 26, up 0.44% for the day but down about 0.7% for the week. Electronic Arts surged 15% on reports of a $50 billion go-private deal, while CarMax plunged 20% after missing Q2 estimates. Navan and Lendbuzz filed for Nasdaq IPOs amid renewed tech IPO activity. Investors await major tech earnings in early October, focusing on AI demand.
1 4 5 6

Stock Market Today

  • Thales (ENXTPA:HO) Shares Decline but DCF Model Indicates Undervaluation
    May 21, 2026, 1:56 AM EDT. Shares of Thales (ENXTPA:HO) have fallen 12.8% over the past month and are down 9.7% year on year, despite strong long-term returns of 79.2% and 203.0% over three and five years respectively. Recent sector-specific developments in aerospace and defense, alongside broader market sentiment, contribute to price volatility. A discounted cash flow (DCF) analysis estimates Thales's intrinsic value at around €306.76 per share, suggesting the current price of €229.50 trades at a 25.2% discount and that the stock is undervalued. The P/E ratio remains a key metric but further valuation aspects need evaluation, as Thales scores 4 out of 6 on Simply Wall St's valuation checks. Investors should consider these factors when assessing the stock's potential.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop